• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, natural history of prostate cancer, room for different interpretations.

作者信息

Ørsted David D, Bojesen Stig E, Kamstrup Pia R, Nordestgaard Børge G

机构信息

Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Eur Urol. 2013 Sep;64(3):396-7. doi: 10.1016/j.eururo.2013.03.049. Epub 2013 Apr 2.

DOI:10.1016/j.eururo.2013.03.049
PMID:23571004
Abstract
摘要

相似文献

1
Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, natural history of prostate cancer, room for different interpretations.
Eur Urol. 2013 Sep;64(3):396-7. doi: 10.1016/j.eururo.2013.03.049. Epub 2013 Apr 2.
2
Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility.
Eur Urol. 2013 Sep;64(3):394-6. doi: 10.1016/j.eururo.2013.03.003. Epub 2013 Mar 13.
3
Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.
Eur Urol. 2013 Oct;64(4):541-3. doi: 10.1016/j.eururo.2013.06.033. Epub 2013 Jun 26.
4
Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.回复：托拜厄斯·诺德斯特伦、安德鲁·维克斯、梅利莎·阿塞尔、汉斯·利尔亚、亨里克·格伦伯格、马丁·埃克隆德。用于预测前列腺癌的四激肽释放酶组合与前列腺健康指数的比较。《欧洲泌尿外科杂志》2015年；68卷：139 - 146页
Eur Urol. 2018 Aug;74(2):e35-e36. doi: 10.1016/j.eururo.2018.04.027. Epub 2018 May 3.
5
Long-term prostate-specific antigen velocity in improved classification of prostate cancer risk and mortality.长期前列腺特异性抗原速率对前列腺癌风险和死亡率的改善分类。
Eur Urol. 2013 Sep;64(3):384-93. doi: 10.1016/j.eururo.2013.01.028. Epub 2013 Feb 4.
6
Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperberg, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30.回复：迈克尔·L·艾森伯格、本杰明·J·戴维斯、马修·R·库珀伯格等。根治性前列腺切除术后超敏前列腺特异性抗原水平检测不到的预后意义。《欧洲泌尿外科杂志》2010年；57卷：622 - 30页
Eur Urol. 2010 Sep;58(3):e33; author reply e34-5. doi: 10.1016/j.eururo.2010.05.006. Epub 2010 May 20.
7
Reply to Michael Froehner's letter to the editor re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol 2013;64:372-8.回复迈克尔·弗勒纳致编辑的信，信中涉及：肯尼斯·G·内普尔、安德鲁·J·斯蒂芬森、多丽娜·卡洛杰里等人的《无合并症男性前列腺癌根治性前列腺切除术、外照射放疗或近距离放射治疗后的死亡率》。《欧洲泌尿外科杂志》2013年；64卷：372 - 378页
Eur Urol. 2014 Mar;65(3):e42. doi: 10.1016/j.eururo.2013.11.036. Epub 2013 Dec 2.
8
Re: Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above: A. Vickers, E. A. Vertosick, D. D. Sjoberg, M. J. Roobol, F. Hamdy, D. Neal, A. Bjartell, J. Hugosson, J. L. Donovan, A. Villers, S. Zappala and H. Lilja J Urol 2017;197:607-613.回复：诊断灰色区域外的4-激肽释放酶检测组合的特性：对直肠指检阳性或前列腺特异性抗原≥10 ng/ml患者的荟萃分析：A. 维克斯、E.A. 韦尔托西克、D.D. 舍贝里、M.J. 鲁博尔、F. 哈姆迪、D. 尼尔、A. 比亚特尔、J. 胡戈松、J.L. 多诺万、A. 维勒斯、S. 扎帕拉和H. 利尔雅 《泌尿外科杂志》2017年；197卷：607 - 613页
J Urol. 2017 Aug;198(2):445-446. doi: 10.1016/j.juro.2017.03.128. Epub 2017 Apr 27.
9
Mortality Similar for Prostate Cancer Therapies.前列腺癌治疗方法死亡率相似。
Cancer Discov. 2016 Dec;6(12):OF7. doi: 10.1158/2159-8290.CD-NB2016-126. Epub 2016 Oct 17.
10
Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403.
J Urol. 2007 Jun;177(6):2396; author reply 2396-7. doi: 10.1016/j.juro.2007.01.172.